ClinicalTrials.Veeva

Menu

Nephronophthisis : Clinical and Genetic Study (NEPHAER)

A

Assistance Publique - Hôpitaux de Paris

Status

Completed

Conditions

Nephronophthisis

Treatments

Genetic: genetic diagnosis

Study type

Interventional

Funder types

Other

Identifiers

NCT01022957
P050605

Details and patient eligibility

About

to describe evolution of Nephronophthisis

Full description

To specify the long term evolution of Nephronophthisis in terms of renal disease as well as extra-renal damages for patients having a confirmed diagnosis of NPHP1, NPHP2, NPHP3, NPHP4, NPHP5, NPHP6 or NPHP8 gene mutation

Enrollment

150 patients

Sex

All

Ages

7+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • NPHP1, NPHP2, NPHP3, NPHP4, NPHP5, NPHP6 or NPHP8 gene mutation
  • 7 years old and older

Exclusion criteria

  • MRI contra-indications

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

150 participants in 1 patient group

Study group
Experimental group
Description:
Neurological, ophthalmological, olfactive exams and cerebral MRI
Treatment:
Genetic: genetic diagnosis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems